Henry de Fex
Bristol-Myers Squibb (United States)(US)
Publications by Year
Research Areas
Synthesis and biological activity, Quinazolinone synthesis and applications, Synthesis and Biological Evaluation, Asymmetric Synthesis and Catalysis, Immune Response and Inflammation
Most-Cited Works
- → Imidazoquinoxaline Src-Family Kinase p56Lck Inhibitors: SAR, QSAR, and the Discovery of (S)-N-(2-Chloro-6-methylphenyl)-2-(3-methyl-1-piperazinyl)imidazo- [1,5-a]pyrido[3,2-e]pyrazin-6-amine (BMS-279700) as a Potent and Orally Active Inhibitor with Excellent in Vivo Antiinflammatory Activity(2004)55 cited
- → Hypochlorous Acid Activates Tyrosine Phosphorylation Signal Pathways Leading to Calcium Signaling and TNF α Production(2002)29 cited
- → Synthesis and SAR of novel imidazoquinoxaline-Based Lck inhibitors: improvement of cell potency(2002)21 cited
- → Synthesis and platelet activating factor (PAF) receptor antagonist activity of 2,5-diarylcylopentanol derivatives(1992)2 cited
- → ChemInform Abstract: Synthesis and Platelet Activating Factor (PAF) Receptor Antagonist Activity of 2,5‐Diarylcyclopentanol Derivatives.(1992)